Skip to content

Cohort study, 2024

Does the COVID-19 booster vaccine affect menstrual cycles in adolescent girls?

Yes. Girls who received the booster had shorter cycles on average, with cycles being 5.35 days shorter than before vaccination, especially in the second cycle after vaccination. Higher stress was also linked to shorter cycles.

Moderate study design 65 adolescent girls aged 13-20 in the United States (47 received COVID-19 booster, 18 did not)

What they did

A prospective study comparing 47 adolescent girls who received a COVID-19 booster vaccine to 18 who did not, all aged 13-20 in the United States. The vaccinated group was tracked for 3 cycles before and 4 cycles after vaccination. The unvaccinated group was tracked for 7 cycles. Researchers measured cycle length, flow, pain, and menstrual symptoms monthly and assessed stress at baseline.

What they found

Girls in the booster group experienced cycles that were on average 5.35 days shorter after vaccination, particularly in the second cycle. The unvaccinated group showed no changes in cycle length. Higher stress was linked to shorter cycles and more menstrual symptoms, regardless of group. There were no differences in menstrual flow, pain, or symptoms between groups.

What it means for you

The booster vaccine was linked to shorter cycles in adolescent girls. The effect appeared temporary or localized to the second cycle. Higher stress also affected cycle length. This is a small study and researchers note further investigation is needed to understand the mechanism. The sample may not represent all adolescents.

47

Adolescents in booster group

18

Adolescents in unvaccinated control group

5.35

Average days shorter in postbooster cycles

About the study

Original title
A Prospective Study of the Relationship of COVID-19 Vaccination to Menstrual Cycle Characteristics in Adolescent Girls
Authors
Payne LA, Seidman LC, Granger SW et al.
Journal
The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Year
2024
Study design
Cohort study
Participants
65
What was tested
COVID-19 booster vaccine
Open access
Yes

Topics